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Introduction: Multiple sclerosis is a common disease of the central nervous system. The aim of this 
study was to determine the effectiveness of acceptance and commitment therapy (ACT) on illness 
perception and adherence to treatment among patients with multiple sclerosis. 
 
Method: The present study was a quasi-experimental with pretest and posttest design. The 
statistical population of this study were all patients with multiple sclerosis under the auspices of the 
MS Society of Tehran in 2019. Forty-five women with multiple sclerosis were purposefully selected 
and randomly divided into two groups: acceptance and commitment therapy (n=15) and control 
group (n=15). Data were obtained with the revised illness perception questionnaire (IPQ-R) and the 
multiple sclerosis treatment adherence questionnaire (MS-TAQ). The repeated measurement 
analysis of variance and SPSS.22 software were used to analyze data. 
 
Result: The results showed that the acceptance and commitment therapy was effective on illness 
perceptions (p<0.001) and adherence to treatment (p<0.001).  
 
Conclusion: It can be concluded that effectiveness of acceptance and commitment therapy focus 
more on the outcome of the thought or how the person relates to their thoughts rather than on the 
content of the thought or attempt to eliminate it. 
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     Introduction 
   Multiple sclerosis (MS) is a common 
disease of the central nervous system (1). 
The main cause of this disease is a damage 
to the myelin sheets of nerve cells that 
transmit neuron messages within central 
nervous system. In this disease, many areas 
of the nervous system are damaged and hard 
tissue is replaced with damaged myelin (2). 
The prevalence of this disease around the 
world is estimated to be two and a half 
million people according to the MS Atlas 
and its prevalence rate in Iran is reported to 
be 5.78 out of every 100,000 people (3). The 
disease is progressive and almost 
irreversible and has different clinical 
manifestations in different people, the most 
important of which are, fatigue, movement 
disorders, visual impairments, sensory 
disorders, cognitive defects, cerebellar 
changes, changes in the autonomic nervous 
system and psychological changes (4). In 
addition to neuro-motor disorders, 
symptoms such as anxiety, weakness 
decreased problem-solving skills occur and 
affect various aspects of a person's life and 
put a lot of pressure on the patient (5). 
In addition to the biological and 
neurological factors involved in this disease, 
psychological factors are   impacted in 
multiple sclerosis (6). Studies have shown 
that the type of strategy that people adopt in 
the face of life pressures, play an important 
role in the onset and course of their disease. 
For example, personality traits and adaptive 
strategies are associated with stress 
tolerance and adaptation to stressful 
situations (7). Several factors influence the 
choice of how to deal with this disease. 
Evidence suggests that differences in how 
different problems are dealt with are not 
only due to the nature or severity of the 
disease, but also to psychological and 
personality factors (8). 
One of these factors is the perception of 
disease. Perception of illness often includes 
information in five dimensions of nature, 
namely labels and symptoms associated with 
the disease (such as fatigue and weakness); 
Cause or belief about the causal causes of 
the onset of the disease; Duration or a 
person's perception of duration in terms of 
acute, periodic or chronic; Outcomes or 
expected results of the disease in terms of 
economic, social, psychological and 
physical effects; And the effectiveness of 
control, treatment, and improvement (9). 
Researchers believe that the difference in 
patients' perceptions and interpretations of 
the causes of the disease is not only due to 
differences in their health, but also people's 
reactions and perceptions of the disease to 
various factors such as social, cultural, 
psychological and personality of People 
depend. In recent years, the importance of 
human empowerment and talent factors has 
been emphasized instead of abnormalities 
and disorders (10). 
Adherence to treatment or a person's 
willingness to follow treatment instructions 
is also one of the factors that can play a 
special role in improving MS (11). Failure to 
take medication and diet may even lead to 
death (12). Several factors play a role in this, 
which can be based on the bio-psycho-social 
model and the model of medical and 
psychological integration (MI-MAP) to 
several psychological factors, including the 
doctor-patient relationship, health control 
center, memory error and other 
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psychological factors (13). Finally, the 
severity of the disease, the degree to which a 
person experiences the disease, can be 
related to various factors, some of which are 
physical, some psychological and some 
environmental and social (14). Among the 
important psychological and social factors, 
we can mention emotional states such as 
anxiety, depression, stress, anger, hostility, 
social support, and social relations (15). 
Previous research and meta-analytic studies, 
have shown the beneficial effects of 
psychological interventions such as 
acceptance and commitment therapy and 
cognitive-behavioral therapies in improving 
the coping mechanisms of patients with MS. 
However, these two approaches therapies 
have not been compared in terms of their 
effectiveness (16). Due to the important role 
of cognition and beliefs in adaptation to 
chronic medical diseases (improving quality 
of life and psychological well-being, disease 
perception and patients' adherence to the 
treatment plan) (17), the third wave 
treatments are always of added value and 
importance in helping such patients. This 
has important implications for the provision 
of psychological interventions to individuals 
with MS, many of whom have limited 
mobility, are easily fatigued, and may find 
additional health-care visits for mental 
health services burdensome and difficult to 
sustain. In sum, given that MS has no known 
cure, there is a need to help individuals learn 
to live with their illness and its physical, 
psychological, and emotional sequelae, and 
to do so in a way that is broadly effective, 
minimally demanding, and time- and cost-
effective (18). 
Therefore, this study is innovative in that it 
targets the underlying issue of disease 
perception and adherence to treatment using 
emerging therapies in the field of 
psychology such as acceptance and 
commitment therapy and cognitive therapy 
based on awareness. The existence of these 
therapies can be used along with drug 
therapies, psychological therapies to 
increase people's resilience, and as a result, 
contribute to the psychological well-being of 
these patients. Thus, the aim of this study 
was to determine the effectiveness of 
acceptance and commitment therapy (ACT) 
on illness perception and adherence to 
treatment of patients with multiple sclerosis. 
 
Method 
The present study was a quasi-experimental 
with pre-test, post-test, and follow-up design 
with a control group. The statistical 
population of this study were all patients 
with MS under the auspices of the MS 
Society of Tehran, Iran in 2019. A total of 
30 women with MS were purposefully 
selected and randomly divided into two 
groups: acceptance and commitment therapy 
(n = 15) and control group (n = 15). The 
required sample size was calculated 45 in 
total based on effect size= 0.40, α=0.95, 1-β 
(err prob) = 0.80 test power and 10% loss 
for each group. Inclusion criteria included 
diagnosis of MS, minimum diploma literacy, 
age ranges between20 to 45 years, relapsing 
of MS after at least 2 years. Exclusion 
criteria included simultaneous exposure to 
other physical problems and illnesses and 
severe psychiatric and neurological 
disorders (based on psychiatric visits). 
Before the experiment, all participants 
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participated in the pre-test and completed all 
the instruments. Then, the experimental 
groups were offered the relevant treatments 
while the control group was on the waiting 
list. Then, at the end of the treatment, all 
participants participated in the post-test. 
Also, two months after the end of treatment 
sessions, follow-up was performed using the 
mentioned scales.  
Acceptance and commitment therapy has 
been done based on Hayes et.al (12) in 8 
sessions of 90 minutes on a weekly basis..  
 
 
Table 1. Acceptance and commitment therapy sessions 
Sessions Content 
First Preliminary explanations, problem conceptualization, patient preparation and pre-test 
implementation, as well as preparing a list of enjoyable activities and its inclusion in 
the weekly program. 
Second and third Familiarity with ACT therapeutic concepts (psychological flexibility, psychological 
acceptance, psychological awareness, cognitive separation, self-visualization, 
personal story, clarification of values and committed action) in six stages 
Fourth Mindfulness training (emotional and wise awareness), teaching patients about what 
skills are observed and described and how skills are not judged, and how these skills 
work. 
fifth First, the focus is on increasing psychological awareness and then people are taught 
how to respond and deal appropriately with their mental experiences and create 
purpose and social lifestyle and practical commitment to them. Counting the positive 
and negative points of couples by each other without any judgment or emotional 
reaction. 
Sixth  Distress tolerance training (permanence skills in crises, distraction, self-relief using 
six senses and mindfulness practice) and reviewing previous sessions 
Seventh Emotion regulation training (goals of emotion regulation training, knowing why 
emotions are important, emotional recognition, reducing vulnerability and emotional 
suffering, increasing positive emotions), changing emotions through action contrary 
to recent affect, practical practice learned, providing feedback by group and therapist. 
Eighth  Increasing interpersonal efficiency (maintaining and maintaining the health of 
relationships, interests, etc.). Teaching important interpersonal skills (describing and 
expressing, asserting and daring, being openly confident, negotiating and self-
esteem). Summing up and executing post-test. 
 
The Revised Illness Perception 
Questionnaire (IPQ-R): The IPQ-R is 
divided into three sections with the identity 
and causal dimensions presented separately 
from the remaining others. In the first 
section the identity scale is presented with 
17 commonly known symptoms (e.g., 
fatigue, dizziness, etc.) and participants are 
asked whether they believe the symptom to 
be related to the illness (1 – yes; 0 – no).  
 
The sum of the yes-rated items forms the 
identity subscale of this version. In the 
following section, consequences, timeline 
acute/chronic, timeline cyclical, coherence, 
personal control, treatment control, and 
emotional representation of the IPQ-R are 
rated on the original 5-point Likert type 
scale: from strongly disagree to strongly 
agree. Using Cronbach's alpha method for 
the components of emotional manifestations, 
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treatment control, disease outcome, 
acute/chronic timeline, disease coherence, 
personal control, and timeline were equal to 
0.93, respectively. 0.85, 0.78, 0.84, 0.86, 
0.78, 0.38 were calculated (19). 
 
The Multiple Sclerosis Treatment 
Adherence Questionnaire (MS-TAQ): 
This tool was designed by Wicks et al. in 
2011 to assess the psychometric 
performance. Wicks and colleagues (20) 
analyzed the dimensions (DMT-Barriers, 
DMT-Side Effects and DMT-Coping 
Strategies) using Cronbach’s alpha. Barriers 
dimension are concerned with patients 
reporting that missing at least one dose of 
the previous 28 days. This dimension is 
about the importance of 13 barriers to 
adherence and rated based on 4-point scale 
from “not important at all” to “extremely 
important” in missing a dose. DMT-Side 
Effects dimension is about the side effects 
caused by treatment and 10 side effects rated 
on a 5-point scale from “never” to “all or 
nearly all of the time” were asked to report 
the frequency by patients. At the end, in the 
DMT-Coping Strategies dimension, all 
patients were asked on a dual yes/no format. 
There are questions about 7 coping 
mechanisms that patients use to reduce the 
side effects they experience within 28 days 
in this dimension (20). The Cronbach alpha 
coefficients of the DMT-Barriers and DMT-
Side Effects dimensions were 0.82 and 0.86. 
For the dimension of DMT-Coping 
Strategies, Cronbach’s alpha value was as 
low as 0.40. Wicks and colleagues think that 
the reason for this low value is a 
consequence of the dual response choices 
and the limited range of tool (20).  
 
In this study, mean and standard deviation 
were used for descriptive analysis. Repeated 
measures analysis of variance, Kolmogorov-
Smirnov test for checking the normality, and 
Tukey post hoc test were also used for the 
inferential analysis of results. The data were 
analyzed using SPSS.22 software. The 
significance level in this study was 0.05. 
 
Results 
The mean (SD) of age in the ACT, and 
control group were 35.06±10.48, and 
35.60±10.58, respectively. There was no 
significant difference between the two 
groups in terms of age.  
.  
 
Table 3- Descriptive indicators of the subjects' scores in three groups in disease perception and adherence 
to treatment
Variable  ACT Control Group 
Step M SD M SD 
Illness perception  Pre-test 77.93 7.54 77.93 5.21 
Post-test 99.60 9.44 76.13 7.01 
Follow-up 106.20 3.96 77.66 8.01 
Adherence to treatment  Pre-test 33.42 4.62 31.48 3.42 
Post-test 45.53 10.87 30.80 3.42 
Follow-up 43.46 7.18 30.13 4.38 
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The first assumption was that the data in the 
dependent variables were normal. 
Kolmogorov-Smirnov test was used to 
check the normality of the data in this study. 
Non-significant results in this test showed 
that the data were normal. The second 
assumption was the homogeneity of the 
variances of the research variables. Leven’s 
test was used to test this assumption. Non-
significant results of this test indicate 
compliance with this assumption. The last 
assumption to be examined is the mixed 
analysis of variance test to check the 
spherical of intragroup variances. That is, 
there must be an equal variance between 
each pair of intragroup conditions (pre-test-
post-test-follow-up). The results of the 
Mauchly test are shown to check compliance 
with the spherical default. The results of the 
mixed analysis of variance are presented in 
Table 2.  
 
 
Table 4 - Results of mixed analysis of variance with within-subject and between-subject factors  
Variable Factors Change 
sources 







Group 21519.24 2 10759.62 19.38 0.001 0.82 
Interaction*
Group 
11785.15 4 2946.28 22.53 0.001 0.71 
Error 4649.60 84 55.35    
Between 
subject 
Group 24360.53 2 12180.26 27.65 0.001 0.93 










3103.58 4 775.89 24.89 0.001 0.54 
Error 2618.53 84 31.17    
Between 
subject 
Group 5048.63 2 2524.31 76.74 0.001 0.78 
Error 1381.46 42 32.89    
 
As shown in Table 4, in relation to the 
intragroup factor, the value of F observed 
for the effect of intervention stages (pre-test, 
post-test and follow-up) at the level of 0.05 
for total disease perception scores (F= 
194.38, p<0.001) and the total score of 
adherences to treatment (p<0.001, 
F=103.37) is significant. As a result, 
between pre-test, post-test and follow-up 
scores of disease perception (F=53.22, 
p<0.001) and adherence to treatment 
(F=24.89, p<0.001) there is a significant  
 
difference in the three stages of treatment. 
The interactive effect between stages and 
groups is also significant. Therefore, it can 
be stated that the difference between the 
mean scores of disease perception and 
adherence to treatment in different stages 
(pre-test, post-test and follow-up) according 
to the variable levels of groups (acceptance 
and commitment therapy group and control 
group) is different. The results of Bonferroni 
post hoc test to compare the pair difference 
of the measurement steps to compare the 
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pair difference of the groups in disease 
perception scores and adherence to 
treatment are shown in Tables 5. 
 
 










Pre-test Post-test -23.37 1.48 0.001 
Pre-test Follow-up -29.22 1.67 0.001 
Post-test Follow-up -5.84 1.53 0.001 
Total score of 
treatment 
adherence 
Pre-test Post-test 11.82 1.06 0.001 
Pre-test Follow-up 16.40 1.21 0.001 
Post-test Follow-up 4.57 1.23 0.025 
 
The results of Bonferroni test in Table 5 
showed that there is a significant difference 
in the total score of disease perception 
between pre-test and post-test and follow-up 
stages (p<0.01). Considering the increase in 
the subjects' scores in the post-test and 
follow-up stages compared to the pre-test 
stage, it can be seen that the subjects 
experienced a significant increase in the 
score compared to the pre-test in the post-
test and follow-up stages. There is a 
significant difference in the total score of 
disease perception between all stages of 
research (pre-test, post-test and follow-up) 
(p<0.001). There is a significant difference 
between the pre-test and post-test and 
follow-up stages in the total score of 
adherences to treatment and the component 
of barriers to adherence (p<0.01). The 
results also show that there is a significant 
difference between the pre-test stage 
compared to the post-test and follow-up in 
the components of life effects and coping 
strategies (p<0.001). Considering the 
decrease in the subjects' scores in the post-
test and follow-up stage compared to the 
pre-test stage, it can be seen that the subjects 
experienced a significant decrease in scores 
compared to the pre-test in the post-test and 
follow-up stage and the effects of 
experimental groups on the research stages 
were significant.  
The results showed that there is a significant 
difference between the study groups in the 
total score of disease perception (p<0.01). 
This means that experimental group 
compared to the control group had a 
significant effect on the subjects' perception 
of the disease and considering that the 
average total score of the disease perception. 
It can be seen that acceptance and 
commitment-based therapy had an effect on 
subjects' perceptions of disease (p<0.05). 
Based on this, it can be found that 
acceptance and commitment-based therapy 
(ACT) affect the perception of patients with 
multiple sclerosis.  
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Figure 1- Modified means of disease perception and treatment scores in the experimental and control 
groups in the pre-test, post-test and follow-up stages
 
    Discussion 
    The results showed that the scores of the 
subjects in the experimental group in the 
post-test and the follow-up period indicated 
the effectiveness of ACT on the components 
of illness perception. Also, considering the 
higher mean scores of illness perception in 
subjects in the acceptance and commitment 
therapy compared to and the control group 
in post-test and follow-up. 
The results of the present study were 
consistent with the findings of Dehkhodai 
and Alipour (21) and Oraki and Sami (22). 
In their study, Saboor and Kakaberi (23) 
performed ACT group therapy on women 
with chronic pain and found that ACT 
therapy reduced pain, depression, stress, and 
increased pain perception. Additionally, 
Kakavand et al. (24) concluded that the 
implementation of acceptance and 
commitment-based therapy reduced negative 
perceptions of stress. Based on these 




psychological consequences such as anger, 
anxiety, fear, and depression due to a 
chronic disease such as MS are inevitable, 
and these factors during the disease can 
cause erosion of physical and mental 
reserves, which in turn weakens the immune 
system and low body resistance. All these 
factors can negatively affect the treatment 
period of the disease and cause the person to 
be disappointed with the treatment and 
ignore the prescribed recommendations (25).  
 
Thus, psychological therapies such as 
acceptance and commitment therapy that 
focuses on awareness of cognitive thoughts 
and biases, and commitment-acceptance 
therapy that simultaneously focuses on 
acceptance and striving for change, help 
patients become aware of their thoughts and 
processes. And improve their thought 
process and communication with thoughts 
by identifying dysfunctional beliefs and 
alternative beliefs. These types of therapies 
(acceptance and commitment therapy) focus 
more on the outcome of the thought or how 
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the person relates to their thoughts rather 
than on the content of the thought or attempt 
to eliminate it. On the other hand, in 
acceptance and commitment therapy, people 
are taught to recognize and accept their 
emotions in the first place, and to deal with 
their emotions and thoughts by reducing the 
futile effort to eliminate and control the 
thought from the position of acceptance 
(26). The person learns to allow for thoughts 
related to the disease and thus reduce the 
threatening nature of these thoughts, thus 
increasing the patient's perception of the 
disease and, of course, following the 
treatment recommendations by increasing 
the power of acceptance and commitment to 
treatment (27-28). 
Moreover, the results showed that 
acceptance and commitment therapy affect 
adherence to treatment. In explaining these 
findings, it can be said that more awareness 
of the body can lead to following medical 
instructions and treatment; In other words, 
self-care behaviors such as following 
treatment are performed well when a person 
establishes a good relationship with their 
body (29). Acceptance and commitment 
therapy in addition to cognitive techniques 
such as identifying dysfunctional and 
alternative thoughts and beliefs with the help 
of exercises such as concentration breathing, 
body checking, sitting meditation, they learn 
to be aware of unpleasant events such as 
chronic illness.. For example, by reducing 
negative thoughts about the disease and 
improving treatment, there is a greater 
tendency to engage in self-care behaviors 
and following medical instructions (30).  
On the other hand, in explaining the 
effectiveness of acceptance and commitment 
therapy on adherence to treatment in patients 
with MS, it can be said that acceptance and 
commitment therapy can be a promising 
method to adherence the treatment 
instructions. The effectiveness of acceptance 
and commitment therapy on basic mediators 
such as executive functions in following the 
treatment (31-32). Adherence to treatment is 
not yet as well-known as it should be, and 
because of the importance of following 
medical guidelines in disease care and 
recovery, it is essential to effectively 
mediate other adherents of treatment using 
psychotherapy interventions such as Identify 
acceptance and commitment therapy (33-
34). 
Regarding research limitations, the results 
were restricted to patients with multiple 
sclerosis, and the controlled and 
experimental literature review related to the 
acceptance and commitment therapy was 
limited. This study was performed only on 
the population of patients with multiple 
sclerosis in Tehran, and caution should be 
exercised in generalizing the results to other 
regions and cities.  It is suggested that this 
research be done in another sample group, 
and its results be evaluated and compared 
with those of this research. Also, the 
therapies introduced in the present study be 
compared with other psychological 
interventions. Finally, the researchers in 
future studies should consider the present 
study results as new research hypotheses. If 
this research is conducted in other cities, and 
the results are evaluated, it is suggested that 
this research be followed up after group 
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